Phenotypic expression of ferroportin disease in a family with the N144H mutation

Gastroenterologie Clinique et Biologique

Volumn 32, Issue 3, 2008, Pages 321-327

  Rosmorduc, O ^a,b,c   Wendum, D ^a,c   Arrive L ^a,c   ElNaggar, A ^a   Ennibi, K ^a   Hannoun, L ^c,d   Charlotte, F ^c,d   Grange J D ^c,e   Poupon, R ^a,b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; IRON OVERLOAD; KUPFFER CELL; LIVER CARCINOMA; LIVER CELL; MACROPHAGE ACTIVATION; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PENETRANCE; PHENOTYPE; PROTEIN EXPRESSION; SPLEEN CELL;

AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; CATION TRANSPORT PROTEINS; CHILD; HEMOCHROMATOSIS; HUMANS; LIVER; LIVER NEOPLASMS; MIDDLE AGED; PEDIGREE; PHENOTYPE;

EID: 50349083662     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2008.01.030     Document Type: Article

References (22)

1. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S., et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108 (2001) 619-623
2. Pietrangelo A., Montosi G., Totaro A., Garuti C., Conte D., Cassanelli S., et al. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med 341 (1999) 725-732
3. Pietrangelo A. Non-HFE Hemochromatosis. Semin Liver Dis 25 (2005) 450-460
4. Njajou O.T., de Jong G., Berghuis B., Vaessen N., Snijders P.J., Goossens J.P., et al. Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics. Blood Cells Mol Dis 29 (2002) 439-443
5. Cazzola M. Genetic disorders of iron overload and the novel "ferroportin disease". Haematologica 88 (2003) 721-724
6. Sham R.L., Phatak P.D., West C., Lee P., Andrews C., and Beutler E. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol Dis 34 (2005) 157-161
7. Schimanski L.M., Drakesmith H., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105 (2005) 4096-4102
8. Abboud S., and Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275 (2000) 19906-19912
9. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
10. Zoller H., and Cox T.M. Hemochromatosis: genetic testing and clinical practice. Clin Gastroenterol Hepatol 3 (2005) 945-958
11. De Domenico I., Ward D.M., Nemeth E., Vaughn M.B., Musci G., Ganz T., et al. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA 102 (2005) 8955-8960
12. Arden K.E., Wallace D.F., Dixon J.L., Summerville L., Searle J.W., Anderson G.J., et al. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut 52 (2003) 1215-1217
13. Arrivé L., Thurnher S., Hricak H., and Price D. Magnetic resonance imaging of splenic iron overload. Eur J Radiol 10 (1990) 98-104
14. Zoller H., McFarlane I., Theurl I., Stadlmann S., Nemeth E., Oxley D., et al. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology 42 (2005) 466-472
15. Pietrangelo A., Corradini E., Ferrara F., Vegetti A., De Jong G., Luca Abbati G., et al. Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease. Blood Cells Mol Dis 37 (2006) 192-196
16. Blanc J.F., de Ledinghen V., Trimoulet P., Le Bail B., Bernard P.H., Saric J., et al. Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation. J Hepatol 30 (1999) 325-329
17. Bralet M.P., Degott C., Belghiti J., and Terris B. Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinoma. J Hepatol 28 (1998) 740
18. Kowdley K.V. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127 (2004) S79-S86
19. Corradini E., Ferrara F., Pollicino T., Vegetti A., Abbati G., Losi L., et al. Disease progression and liver cancer in the ferroportin disease. Gut 56 (2007) 1030-1032
20. Chenoufi N., Loreal O., Drenou B., Cariou S., Hubert N., Leroyer P., et al. Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate. J Hepatol 26 (1997) 650-658
21. Hann H.W., Stahlhut M.W., and Hann C.L. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 11 (1990) 566-569
22. Vautier G., Bomford A.B., Portmann B.C., Metivier E., Williams R., and Ryder S.D. p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis. Gastroenterology 117 (1999) 154-160